Roku Inc
Media
Roku Inc (ROKU) Stock News
The latest ROKU headlines and market coverage — 6 recent stories, updated throughout the day.
- Zacks Investment Research·
Roku (ROKU) Ascends While Market Falls: Some Facts to Note
Roku (ROKU) closed at $157.45, up 1.63%, outperforming the broader market declines. The company is expected to report strong earnings growth of 243.75% EPS and 16.49% revenue growth. With a Zacks Rank #1 (Strong Buy) rating and positive estimate revisions, analysts show confidence in the company's near-term performance, though the stock trades at a premium valuation with a Forward P/E of 55.75 compared to its industry average of 11.11.
- Zacks Investment Research·
Bullish EPS Revisions Back IBKR, SNDK, and ROKU
Interactive Brokers, SanDisk, and Roku all carry Zacks Rank #1 (Strong Buy) ratings driven by positive earnings estimate revisions and strong business fundamentals. IBKR benefits from account growth and trading activity, SNDK is seeing explosive AI-driven datacenter demand with improved NAND pricing, and ROKU is improving monetization of its streaming platform through advertising and subscriptions.
- GlobeNewswire Inc.·
Halper Sadeh LLC is Investigating Whether DAN, ROKU, TBRG, AFBI are Obtaining Fair Deals for their Shareholders
Investor rights law firm Halper Sadeh LLC is investigating four proposed mergers and acquisitions to determine if shareholders are receiving fair deals. The investigations focus on Dana Incorporated's sale to Eaton Corporation, Roku's acquisition by Fox Corporation, TruBridge's sale to Inventurus Knowledge Solutions, and Affinity Bancshares' merger with Fidelity BancShares. The firm is examining potential securities law violations and fiduciary duty breaches, particularly regarding insider benefits and terms that may limit competing offers.
- GlobeNewswire Inc.·
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)
Brodsky & Smith law firm has announced investigations into multiple merger transactions, including Apogee Therapeutics (acquired by AbbVie for $135.11/share), Roku (acquired by Fox for $160/share), TruBridge (acquired by Inventurus for $26.25/share), and Organon (acquired by Sun Pharmaceutical for $14/share). The investigations focus on whether the respective boards breached fiduciary duties by failing to conduct fair processes and whether deal consideration provides fair value to shareholders.
- GlobeNewswire Inc.·
Halper Sadeh LLC is Investigating Whether SLP, ROKU, TBRG are Obtaining Fair Deals for their Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential violations of federal securities laws and breaches of fiduciary duties. The investigations concern Simulations Plus' sale to Altaris for $18.50 per share, Roku's sale to Fox Corporation for $96.00 cash plus 0.9693 Fox shares per share, and TruBridge's sale to Inventurus Knowledge Solutions for $26.25 per share. The firm is seeking increased consideration, additional disclosures, and other relief on behalf of shareholders.
- GlobeNewswire Inc.·
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)
Brodsky & Smith law firm is investigating four merger transactions to determine whether company boards breached fiduciary duties by failing to conduct fair processes and provide fair value to shareholders. The investigations involve Simulations Plus ($18.50/share), Roku ($160.00/share), TruBridge ($26.25/share), and Organon ($14.00/share).